首页> 外文期刊>Annals of surgical oncology >CXCL10 Expression Status is Prognostic in Patients with Advanced Thoracic Esophageal Squamous Cell Carcinoma
【24h】

CXCL10 Expression Status is Prognostic in Patients with Advanced Thoracic Esophageal Squamous Cell Carcinoma

机译:CXCL10表达状态是晚期胸段食管鳞癌患者的预后。

获取原文
获取原文并翻译 | 示例

摘要

Background. CXCL10, a member of the CXC chemokine family, is known to mediate chemotaxis, apoptosis, angiogenesis, and cell growth. It is also reportedly involved in tumor development and can affect prognosis in several cancers. However, the precise relationship between CXCL10 and the prognosis of patients with esophageal squamous cell carcinoma (ESCC) is not fully understood.
机译:背景。 CXCL10是CXC趋化因子家族的成员,已知可介导趋化性,细胞凋亡,血管生成和细胞生长。据报道,它也参与肿瘤的发展,并可能影响几种癌症的预后。但是,尚不完全了解CXCL10与食管鳞状细胞癌(ESCC)患者的预后之间的确切关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号